phosphoramide mustard has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crowther, D; Dougal, M; Elder, RH; Lee, SM; Margison, GP; Rafferty, JA; Scarffe, JH | 1 |
| Hansen, J; Jacobson-Kram, D; Kolodner, K; McDiarmid, MA; Strickland, PT | 1 |
2 other study(ies) available for phosphoramide mustard and Leukemia
| Article | Year |
|---|---|
Cyclophosphamide decreases O6-alkylguanine-DNA alkyltransferase activity in peripheral lymphocytes of patients undergoing bone marrow transplantation.
Topics: Acrolein; Adenosine Triphosphatases; Adolescent; Adult; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Female; Humans; Kinetics; Leukemia; Lymphocytes; Lymphoma, Non-Hodgkin; Male; Methyltransferases; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Phosphoramide Mustards; Recombinant Proteins; Transplantation, Autologous | 1992 |
Baseline and phosphoramide mustard-induced sister-chromatid exchanges in cancer patients treated with cyclophosphamide.
Topics: Breast Neoplasms; Cells, Cultured; Female; Humans; Leukemia; Lymphocytes; Male; Neoplasms; Phosphoramide Mustards; Reference Values; Sister Chromatid Exchange | 1990 |